Cytokinetics Inc Capital Reinvestment Ratio
Cytokinetics Inc capital reinvestment ratio. Cytokinetics Inc (CYTK) has a Capital Reinvestment Ratio of 0.13x as of December 2020, meaning it reinvests 0% of its operating cash flow ($52.15 Million) in capital expenditures ($6.55 Million). See how much free cash does Cytokinetics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cytokinetics Inc (2009–2020)
Capital reinvestment ratio of Cytokinetics Inc from 2009 to 2020. This chart tracks Cytokinetics Inc's Capital Reinvestment Ratio across 4 annual periods. See CYTK free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cytokinetics Inc Capital Reinvestment Ratio by Year (2009–2020)
Cytokinetics Inc capital reinvestment ratio by year from 2009 to 2020. For the full cash flow conversion analysis, see cash flow conversion of Cytokinetics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.24x | $8.94 Million | $11.05 Million | ▲ +2763.6% |
| 2016 | 0.04x | $36.98 Million | $1.60 Million | ▼ -62.5% |
| 2015 | 0.12x | $4.88 Million | $562.00K | ▲ +76.1% |
| 2009 | 0.07x | $8.42 Million | $550.00K | — |